Delaware Jury: Guardant Willfully Infringed Patents With DNA Sequencing Kits
WILMINGTON, Del. — Jurors empaneled in Delaware federal court delivered a win to the owner and exclusive licensee of two cancer-detection patents, deeming the technology willfully infringed by Guardant Health Inc....To view the full article, register now.
Already a subscriber? Click here to view full article